First Bancorp’s Pfizer PFE Stock Holding History

First Bancorp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$496K	Buy	20,600 +2,325	+13%	+$60.8K	0.2%	80
2026 Q1	$513K	Hold	18,275	–	–	0.26%	75
2025 Q4	$455K	Buy	18,275 +750	+4%	+$18.9K	0.24%	80
2025 Q3	$447K	Sell	17,525 -690	-4%	-$17K	0.24%	81
2025 Q2	$442K	Buy	18,215 +1,145	+7%	+$26.7K	0.25%	83
2025 Q1	$433K	Sell	17,070 -777	-4%	-$20.3K	0.28%	79
2024 Q4	$473K	Buy	17,847 +361	+2%	+$9.79K	0.32%	72
2024 Q3	$506K	Sell	17,486 -400	-2%	-$11.7K	0.35%	61
2024 Q2	$500K	Buy	17,886 +3,825	+27%	+$105K	0.37%	59
2024 Q1	$390K	Buy	14,061 +303	+2%	+$8.41K	0.3%	79
2023 Q4	$396K	Sell	13,758 -3,740	-21%	-$113K	0.31%	71
2023 Q3	$580K	Sell	17,498 -100	-0.6%	-$3.54K	0.51%	44
2023 Q2	$645K	Sell	17,598 -300	-2%	-$11.7K	0.53%	45
2023 Q1	$730K	Buy	17,898 +1,888	+12%	+$81.5K	0.63%	39
2022 Q4	$820K	Sell	16,010 -200	-1%	-$9.59K	0.69%	38
2022 Q3	$709K	Buy	16,210 +1,300	+9%	+$63.2K	0.64%	39
2022 Q2	$782K	Buy	14,910 +982	+7%	+$50K	0.74%	32
2022 Q1	$721K	Sell	13,928 -45	-0.3%	-$2.33K	0.66%	33
2021 Q4	$825K	Sell	13,973 -2,146	-13%	-$106K	0.72%	31
2021 Q3	$694K	Buy	+16,119	New	+$714K	0.66%	36
2021 Q1	$560K	Buy	+15,461	New	+$549K	0.55%	42

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Bancorp's PFE Position: Q2 2026 in Review

First Bancorp increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $60.8K and bringing the position to 20,600 shares worth $496K. The position accounts for 0.2% of the portfolio, ranked #80.

First Bancorp first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $825K in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

First Bancorp held 20,600 shares of Pfizer worth $496K as of Q2 2026.
First Bancorp bought 2,325 Pfizer shares in Q2 2026, an estimated $60.8K.
Pfizer made up 0.2% of First Bancorp's portfolio in Q2 2026, its #80 holding.
First Bancorp first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
First Bancorp's Pfizer position peaked at $825K in Q4 2021.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.